PT - JOURNAL ARTICLE AU - Noha M. Elemam AU - Haifa Hannawi AU - Issa Al Salmi AU - Kashif Bin Naeem AU - Fahdah Alokaily AU - Suad Hannawi TI - Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates AID - 10.15537/smj.2021.2.25700 DP - 2021 Feb 01 TA - Saudi Medical Journal PG - 170--180 VI - 42 IP - 2 4099 - http://smj.org.sa/content/42/2/170.short 4100 - http://smj.org.sa/content/42/2/170.full SO - Saudi Med J2021 Feb 01; 42 AB - Objectives: To compare risk factors and clinical outcomes among COVID-19 patients with or without diabetes in the United Arab Emirates (UAE).Methods: Data of 350 COVID-19 positive patients, admitted to Al Kuwait Hospital in Dubai, UAE, from February to May 2020 was collected retrospectively, including demographic data, clinical symptoms, blood tests, as well as radiographical assessments, and clinical outcomes of COVID-19. The design of the study is a retrospective cohort study.Results: COVID-19 patients with diabetes belong to an older age group, had a higher percentage of male patients, exhibited more lymphopenia and neutrophilia, and higher ferritin levels. Additionally, patients with diabetes presented fever and shortness of breath (SOB), displayed more bilateral airspace consolidation and opacities in their chest x-ray and CT scans, compared to non-diabetics. A higher percentage of critical, ICU-admitted, and death of COVID-19 cases in the diabetic group was also reported. This was along with a concomitant increase in C-reactive protein, procalcitonin, and lactate dehydrogenase levels.Conclusions: Diabetes is considered a comorbidity as diabetic patients showed more severe COVID-19 symptoms that led to critical clinical outcomes such as ICU admission and death.